Biomedical application of orexin/hypocretin receptor ligands in neuroscience.
Boss
Christoph
C
Drug Discovery and Preclinical Research & Development, Actelion Pharmaceuticals Ltd., CH-4123 Allschwil, Switzerland. christoph.boss@actelion.com
Brisbare-Roch
Catherine
C
Jenck
Francois
F
D000818:Animals; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008024:Ligands; D009290:Narcolepsy / Q000188:drug therapy* / Q000209:etiology; D009479:Neuropeptides; D064446:Orexin Receptors; D000068797:Orexins; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000502:physiology; D018013:Receptors, Neuropeptide / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000502:physiology; D013329:Structure-Activity Relationship
D047908:Intracellular Signaling Peptides and Proteins; D008024:Ligands; D009479:Neuropeptides; D064446:Orexin Receptors; D000068797:Orexins; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide